Process for producing a hydrate of an acid addition salt of a compound, hydrate of an acid addition salt of a compound, pharmaceutical or veterinary composition, use of a hydrate agent for use as an inhibitor or p-glycoprotein, and , methods for modulating p-gp modulated mdr in tumor treatment, for enhancing cytotoxicity of a cytotoxic agent to a tumor cell, for treating a disease in which the responsible pathogen exhibits multidrug resistance, and for enhancing a characteristic of a therapeutic agent
GB0301736D0
Pharmaceutical compounds
GB0123669D0
Pharmaceutical compounds
GB0113345D0
Pharmaceutical compounds
GB0105595D0
Heteroaromatic [a] phenazine carboxamides as topoisomerase inhibitors
GB0101227D0
2-oxo, 4-hydroxy pyrroles and quinolines
GB0101225D0
Diketopiperazines
GB0005366D0
Pharmaceutical compounds
GB9928542D0
Pharmaceutical compounds
GB9814844D0
Cytokine production inhibitors
GB9808196D0
Cytokine production inhibitors
CN1240431A
Process for preparation of N-[2-(dimethylamino) ethyl] acridine-4-carboxamide
ZA9709329B
Pharmaceutical compounds
SK50599A3
Process for the preparation of n-[2- -(dimethylamino)ethyl]acridine-4-carboxamide
MY118642A
Anthranilic acid derivatives as multi drug resistance modulators
